US 11,058,668 · Application 16/361,587 · Granted Jul 13, 2021
US 11,058,668
Methods of treating ttr amyloidosis using ag10
Estimated expiration
March 22, 2039
12y 188d remaining
Earliest effective filing
Mar 22, 2019
+ 20 years
Mar 22, 2039
PTA +0d
Mar 22, 2039
No TD
—
Final
Mar 22, 2039
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- March 22, 2019
- Earliest effective filing
- March 22, 2019
- Issue date
- July 13, 2021
- PTA
- 0 days
- Base expiry (before PTA)
- March 22, 2039
March 22, 2019 + 20 years = March 22, 2039
- PRO62/647,411 — Provisional — not used for base term
- PRO62/765,096 — Provisional — not used for base term
- PRO62/731,629 — Provisional — not used for base term
- PRO62/758,235 — Provisional — not used for base term
- PRO62/810,651 — Provisional — not used for base term
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 16/361,587 · US 11,058,668
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 11,058,668: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US11058668Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.